The evolving management of acute right-sided heart failure in cardiac transplant recipients

Journal of the American College of Cardiology

Volumn 38, Issue 4, 2001, Pages 923-931

  Stobierska Dzierzek, Bozena ^a   Awad, Hamdy ^a   Michler, Robert E ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA BALLOON; BLOOD PRESSURE REGULATION; CORONARY ARTERY BLOOD FLOW; HEART AFTERLOAD; HEART ASSIST DEVICE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART PRELOAD; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; LUNG VASCULAR RESISTANCE; LUNG VASOCONSTRICTION; MEDICAL LITERATURE; OXYGEN BREATHING; PATIENT SELECTION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; RISK FACTOR; SYNDROME; TIDAL VOLUME; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0034810366     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01486-3     Document Type: Article

References (56)

1. The Registry of the International Society for Heart and Lung Transplantation: Seventeenth official report - 2000
2. The limits of right ventricular compensation following acute increase in pulmonary, circulatory resistance
3. Determinants of operative risk in human heart transplantation
4. Analysis of morbid events and risk factors for death after cardiac transplantation
5. Pulmonary vascular resistance and the risk of heart transplantation
6. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation
7. Pretransplantation risk factors for the death after heart transplantation: A multi-institutional study: The Transplant Cardiologist Research Database group
8. Intermediate follow-up of pediatric heart transplant recipients with elevated pulmonary vascular resistance index
9. New concepts of right heart failure
10. Hemodynamics of the right ventricle in normal and diseased states
11. The dose-dependent effects of halothane on right ventricular contraction pattern and regional inotropy in swine
12. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: Testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high-risk group
13. Reduction of pulmonary hypertension by nitroprusside
14. Adenosine infusion for the reversal of pulmonary vasoconstriction in biventricular failure: A good test but a poor therapy
15. Reevaluating the significance of pulmonary hypertension before cardiac transplantation: Determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality
16. Does preexisting elevated pulmonary vascular resistance (transpulmonary gradient >15 mm Hg or >5 wood) predict early and long-term results after orthotopic heart transplantation?
17. The problem of pulmonary hypertension in the potential cardiac transplant recipient
18. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation
19. Perioperative management of pulmonary hypertension after heart transplantation in childhood
20. Pulmonary circulation
21. Prevention of complement induced pulmonary hypertension and improvement of right ventricular function by selective thromboxane receptor antagonism
22. Prostaglandin E1: An effective treatment of right heart failure after orthotopic heart transplantation
23. Effect of nitroglycerin in patients with increased pulmonary vascular resistance undergoing cardiac transplantation
24. Right ventricular assist and prostacyclin infusion for allograft failure in the presence of high pulmonary vascular resistance
25. Pulmonary vasodilatation after heart transplantation: A comparison among prostacyclin, sodium nitroprusside, and nitroglycerin on right ventricular function and pulmonary selectivity
26. Vasodilator therapy after heart transplantation: Effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside
27. Prostacyclin in the management of pulmonary hypertension after heart transplantation
28. Adenosine effectively controls pulmonary hypertension after cardiac operations
29. Hemodynamic and metabolic effects of infused adenosine in man
30. Effect of infused adenosine on cardiac output and systemic resistance in normal subjects
31. Circulatory and respiratory effects of infused adenosine in conscious man
32. The effects of dopamine and isoproterenol on the pulmonary circulation
33. Hemodynamic effects of prostaglandin E1 and isoproterenol early after cardiac operations for mitral stenosis
34. Acute right ventricular failure following heart transplantation: Improvement with prostaglandin E1 and right ventricular assist
35. Prostaglandin E1 for treatment of elevated pulmonary vascular resistance in patients undergoing cardiac transplantation
36. Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: Comparative effects of various pharmacologic agents
37. Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension
38. Prostaglandin E1-induced moderation of elevated pulmonary vascular resistance: Survival on waiting list and results of orthotopic heart transplantation
39. Inhaled nitric oxide: Therapeutic applications in cardiothoracic surgery
40. Inhaled nitric oxide therapy
41. NIOSH recommendations for occupational safety and health standards 1988
42. Low doses of inhaled nitric oxide in heart transplant recipients
43. Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension
44. Cardiovascular effects of milrinone
45. Treatment of perioperative low cardiac output syndrome
46. Selecting an inotrope for the cardiac surgery patient
47. Tri-iodothyronine optimizes sheep ventriculoarterial coupling for work efficiency
48. Mechanical circulatory assistance after heart transplantation
49. Right heart assist for acute right ventricular failure after orthotopic heart transplantation
50. Experience with right ventricular assist devices for perioperative right-sided circulatory failure
51. Relation between recipient: Donor body size match and hemodynamics three months after heart transplantation
52. Evolution of hemodynamics after orthotopic heart and heart-lung transplantation: Early restrictive patterns persisting in occult fashion
53. Oversizing of donor hearts: Beneficial or detrimental
54. Relationship of cardiac allograft size and pulmonary vascular resistance to long-term cardiopulmonary function
55. Preliminary experience with inhaled nitric oxide for acute pulmonary hypertension after heart transplantation
56. Prostaglandin E1 infusion for right ventricular failure after cardiac transplantation